How many institutions held BOLT - Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value in Q2 2025?

24 institutional investors reported BOLT - Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value for Q2 2025. Use the holders table for investor-level position and value details.

Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT)

Q: What does CUSIP 097702203 represent in this 13F holders report?

CUSIP 097702203 is the security identifier for BOLT - Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value used to aggregate holder disclosures.

CUSIP: 097702203

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, $0.00001 par value
Shares outstanding: 1,901,870
Total 13F shares: 887,525
Share change: +887,525
Total reported value: $5,096,477
Price per share: $5.77
Number of holders: 24
Value change: +$5,096,477
Number of buys: 24

Quarterly Holders Quick Answers

What is CUSIP 097702203?
CUSIP 097702203 identifies BOLT - Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025

Recent filing periods for CUSIP 097702203:

Q4 2025 Q3 2025 Q2 2025

Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT) as of Q2 2025

As of 30 Jun 2025, Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 887,525 shares. The largest 10 holders included Vivo Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Sofinnova Investments, Inc., Pivotal bioVenture Partners Investment Advisor LLC, VANGUARD GROUP INC, Nan Fung Group Holdings Ltd, SAMSARA BIOCAPITAL, LLC, Board of Trustees of The Leland Stanford Junior University, Pfizer Inc, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 25 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.